Venture-Backed Startups

2 investors

0 investors

Adbrain links customer data across mobile devices, desktops, and connected TVs to build a unified view of each individual. Marketing teams use this cross-device identity data to target audiences, allocate ad spend, and maintain consistent messaging across channels.

4 investors

AdBro provides a display advertising channel using in-image ad units placed across local and global publishers, offering full-service campaign delivery including creative adaptation, targeting, media planning, and reporting. It serves agencies and advertisers seeking to reach engaged audiences with guaranteed outcomes.

2 investors

Adbuffs is a performance marketing agency for direct-to-consumer brands, offering strategy, media buying, creative, retention, and incrementality measurement to drive profitable revenue growth. It works with DTC brands across fashion, beauty, and wellness, and positions itself as India's first agency to integrate marketing measurement and incrementality.

1 investor

0 investors

0 investors

0 investors

ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology. It operates in the biotech and pharmaceutical industry.

4 investors

Regional Health Properties, Inc. owns, operates, and invests in healthcare real estate and operating businesses centered on long-term care, senior housing, and pharmacy services.

0 investors

0 investors

Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs. The company translates scientific innovation into clinically differentiated medicines for patients with advanced solid tumors and other cancer types.

1 investor

Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.

8 investors

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.

3 investors

Adchieve provides automated advertising and campaign management solutions for travel and hospitality providers, including independent hotels, hotel chains, and vacation rental platforms. The platform optimizes Google Ads spending and increases direct bookings while reducing acquisition costs through data-driven bid management and inventory synchronization.

1 investor

AdCities operates a platform for planning, activating, and measuring out-of-home (OOH) advertising campaigns using its AI model OMI (Outdoor Media Intelligence), which combines mobility data, points of interest, and user profiles to build audiences and select media. It serves brands, media agencies, and publishers looking to buy, sell, and measure both digital and analog outdoor advertising inventory.

3 investors

ADCITIES runs out-of-home (OOH) advertising campaigns using contextual AI that interprets real-world signals such as location, time, mobility, and events to place brand ads where audience affinity is highest. It serves advertisers and brands seeking real-world contextual advertising.

1 investor

AdClean (industrial division AdTech) develops a non-toxic disinfection and hygiene formula that replaces chemicals like chlorine, peracetic acid, quaternary ammonium and caustic soda for industrial pathogen control. It serves food and beverage, animal protein, energy, mining, general industrial and wastewater (RILes) treatment sectors, aiming to improve food safety, reduce costs and lower environmental impact.

1 investor

Adclear provides a compliance platform designed to help financial brands manage regulatory requirements and streamline content creation across multiple channels.

1 investor

AdcoTx is a University of Cambridge spin-out developing cancer therapies, including personalized treatments, immunotherapies, cell and gene therapies, and targeted drug delivery systems. The company is linked to the MRC Laboratory of Molecular Biology in Cambridge, UK.

1 investor

Adcubum develops software solutions for the health and accident insurance sector, serving insurance companies as a market leader in Switzerland. The company also builds AI-based tools, including an agent-based RAG assistant being developed into a multi-tenant SaaS product for insurers, with operations in Switzerland, Germany, and Croatia.

1 investor

Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology. Its lead candidate, ADCX-020, is being evaluated in a Phase 1 study in patients with advanced solid tumors.

7 investors

Add-Life creates virtual reality experiences designed to promote neuroplasticity and support brain recovery and health. The platform is intended for individuals seeking therapeutic benefits through VR-guided activities that encourage neural adaptation.

1 investor

Addon Optics develops a technology platform that automates and optimizes the manufacturing and distribution of ophthalmic lenses for optical labs, retailers, and distributors. The platform aims to reduce production costs, capital requirements, and labor while accelerating production speed.

1 investor